Pessary Market Size, Share & Trends Analysis Report By Type (Gellhorn, Ring, Donut), By End-use (Hospitals, Ambulatory Surgical Centers, Clinics), By Region (North America, Europe, Asia Pacific, Latin America, MEA), And Segment Forecasts, 2021 - 2028

Report Overview

The global pessary market size was valued at USD 239.9 million in 2020 and is expected to expand at a CAGR of 9.2% from 2021 to 2028. Increasing prevalence of pelvic organ prolapse, growing geriatric population that is prone to pelvic organ prolapse, easy product availability, changing lifestyles, and rapid evolution of noninvasive treatment options are expected to fuel market growth. Stress urine incontinence is higher in patients with poor nutritional status which results in weakening of pelvic muscles. Thus, the demand for advanced pelvic support devices is expected to show steep growth in upcoming years.

Vaginal pessaries are one of the most preferred treatment options for organ prolapse and incontinence as they provide simple, affordable, and safe solutions. These factors contribute to a higher patient satisfaction rate as compared with the alternative treatment options. Thus, vaginal pessaries are now considered as first-line treatment of pelvic prolapse and/or stress urinary incontinence. Pelvic Organ Prolapse (POP) affects women of all ages. However, elderly women are more susceptible to POP complications. According to studies from the US Food and Drug Administration, the number of women with POP is predicted to rise by 46 percent by 2050, to 4.9 million.

Pessaries were preferred as a temporary measure against delayed elective surgeries during the COVID-19 pandemic. However, the overall demand declined significantly during the first wave of COVID-19. This can be attributed to a decrease in overall footfall in clinics and hospitals during the pandemic. Lockdown and restriction on gathering directly affected the production during the first wave of COVID-19. However, the production units started reopening during the third quarter of 2020. The adoption of vaginal pessaries is impacted by the factors such as patient discomfort and fear of side effects. To address these issues, regulatory agencies such as the FDA and NICE have developed new guidelines for manufacturers.

Frequent introduction of new products, heavy focus on R&D by market players and universities, geographical expansion by key players, and several government initiatives are some of the major factors likely to boost the market during the forecast period. Cosm Medical Corporation received approval from Health Canada Investigational Testing Authorization (ITA) for its clinical study for its product gynethotics, which helps in making customized gynecological prosthetics. Cosm designs a customized pessary based on the patient's specific anatomy and lifestyle needs with a modernized pelvic floor measurement system using novel ultrasound imaging technology.

Type Insights

The ring pessary segment dominated the pessary market and accounted for the largest revenue share of 58.9% in 2020. The segment is expected to witness significant CAGR throughout the forecast period owing to the factors such as ease of usage and patient comfort. The ring pessary is appropriate for all stages of POP. Clinicians favor ring pessaries because of the simplicity with which they may be inserted and removed. These are most effective in the early stages of prolapse, but they can be used at any stage of pelvic organ prolapse.

Gehrung, shaatz, oval, cube, and shelf are few other pessaries that are widely in use. Other support pessaries, on the other hand, are maybe more useful for advanced prolapse but are more difficult for the patient to handle. This device uses suction to support areas that may be sagging or bulging due to prolapse. Most of the pessaries available in the market nowadays are comprised of silicone, which is highly compatible material. They're non-allergenic, long-lasting, autoclavable, and simple to remove and replace. The type of pessary to use is determined by a number of parameters, including the type and degree of prolapse.

End-use Insights

The hospital segment dominated the vaginal pessary market and accounted for the largest revenue share of 44.2% in 2020. This growth is owing to the high demand for pessaries in post-operative and bedridden in-patients. Increasing awareness about organ prolapse, urinary incontinence, and inclusion of pessaries in private insurances are some of the factors boosting the segment growth. Also, the hospital settings are adopting minimally invasive procedures for placing a pessary to reduce post-operative complications and accelerate the recovery rate.

The clinic segment is expected to witness the fastest CAGR of 9.8% in the market for pessary during the forecast period. This can be attributable to affordable pessary fitting procedures, limited hospital stays, and higher convenience for the geriatric population. Ambulatory clinical centers are also expected to grow at a significant rate during the forecast period, growing awareness about ambulatory centers is estimated to spur the growth of the segment.

Regional Insights

North America dominated the market and accounted for the largest revenue share of 41.1% in 2020. The market has a high impact due to factors such as an aging female population, lifestyle changes that cause hormonal disruptions, the rising prevalence of pelvic organ prolapse, and increased health awareness. According to the US Department of Health and Human Services, 3.3 million women in the US have experienced pelvic organ prolapse, this number is expected to rise to 4.9 million by 2050 due to a probable link with aging.

In Asia Pacific, the market for pessary is expected to witness exponential growth over the forecast period. The regional market's fastest growth rate is expected to be linked to emerging economies, an aging population, and increased healthcare awareness. The geriatric population is more vulnerable to urinary inconsistency and POP, providing a large target market in the area, with Japan, China, and India being the primary regional providers. Increasing medical tourism is another important element driving the market in the region.

Key Companies & Market Share Insights

The market is highly competitive, marked by the presence of a large number of domestic as well as international players. Some of the key strategic initiatives undertaken by market players include new product development, mergers, acquisition, partnership, and collaboration. For instance, the Arabin Cerclage pessary was developed by a German-based Dr. Arabin GmbH to support the cervical area in pregnant women who are at risk of preterm labor. Some of the prominent players in the pessary market include:

• CooperSurgical Inc.

• Bliss GVS Pharma

• MedGyn

• Panpac Medical Corporation

• Bioteque America

• Personal Medical Corporation

• Dr. Arabin GmbH & Co. KG

• Integra Lifesciences

• Wallach Surgical Devices

Pessary Market Report Scope

Segments Covered in the Report

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2016 to 2028. For the purpose of this study, Grand View Research has segmented the global pessary market report on the basis of type, end-use, and region:

• Type Outlook (Volume, Units; Revenue, USD Million, 2016 - 2028)

  • Gellhorn

  • Ring

  • Donut

  • Others

• End-use Outlook (Volume, Units; Revenue, USD Million, 2016 - 2028)

  • Hospitals

  • Ambulatory Surgical Centres

  • Clinics

• Regional Outlook (Volume, Units; Revenue, USD Million, 2016 - 2028)

  • North America

    • U.S.

    • Canada

  • Europe

    • U.K.

    • Germany

    • France

    • Italy

    • Spain

    • Sweden

    • Norway

    • Russia

  • Asia Pacific

    • Japan

    • China

    • India

    • South Korea

    • Australia

  • Latin America

    • Brazil

    • Mexico

    • Argentina

    • Colombia

  • Middle East and Africa

    • South Africa

    • Saudi Arabia

    • UAE

    • Qatar

    • Turkey